Overview

KAIRAX SUB-Q™ is a CE-certified, monophasic hyaluronic acid (HA) dermal filler engineered for deep volumization and facial contouring. Its high-viscosity gel provides structural support in areas with significant volume loss, such as cheeks, jawline, chin and nose.

Product Range

• Kairax Fine™: Low-viscosity for fine lines
• Kairax Deep™: Mid-viscosity for moderate folds
• Kairax Sub-Q™: High-viscosity for deep augmentation

Each variant is supplied in a 1.0 mL prefilled syringe.

Composition

• Hyaluronic Acid: 24 mg/mL cross-linked for maximum lift
• Lidocaine Hydrochloride: 0.3 % for patient comfort

Indications

• Deep to severe wrinkles and folds (nasolabial, marionette lines)
• Structural augmentation of cheeks, chin, jawline and nose
• Restoration of age-related volume loss

Administration

• Needles Included: 2 × 25 G × ½″ ultra-thin wall
• Injection Depth: Deep dermis to subcutaneous or supraperiosteal layer
• Technique: Linear threading or bolus deposits by a trained clinician

Efficacy & Duration

• Onset: Immediate volumization and contour definition
• Duration: 12–18 months, depending on individual metabolism and treatment area

Safety & Precautions

• Single-use only; do not re-sterilize
• Avoid mixing with other products and injecting into implant sites
• Pre-treatment: avoid NSAIDs, aspirin or high-dose vitamin C one week prior
• Post-treatment: avoid UV exposure, extreme temperatures and pressure on treated areas for two weeks
• Common, transient reactions: redness, swelling, bruising or tenderness

Storage & Handling

• Temperature: 2–25 °C; protect from direct sunlight and freezing
• Shelf Life: 24 months from manufacture

Specifications

• Type: Monophasic, high-cohesivity gel
• HA Concentration: 24 mg/mL
• Lidocaine: 0.3 %
• Viscosity Index: Highest in the Kairax range
• Packaging: 1 × 1.0 mL syringe with 2 × 25 G needles